Home | Site Map | Contact Us | Graphics VersionPrinter Version |

Amarin

Main Navigation

  • ABOUT US
    • COMPANY PROFILE
    • STRATEGY
    • SENIOR MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • CONTACT US
  • THERAPEUTIC FOCUS
    • CARDIOVASCULAR
  • PRODUCTS
    • PIPELINE
    • AMR101 for Reducing Cardiovascular Risk
  • PARTNERING
    • PARTNERING
  • INVESTOR RELATIONS
    • OVERVIEW
    • PRESS RELEASES
    • EVENTS & PRESENTATIONS
    • CORPORATE GOVERNANCE
      • AUDIT COMMITTEE
      • REMUNERATION COMMITTEE
      • CODE OF ETHICS
      • MEMORANDUM AND ARTICLES OF ASSOCIATION
    • FINANCIAL INFORMATION
      • SEC FILINGS
      • ANNUAL REPORTS
      • QUARTERLY REPORTS
      • KEY RATIOS
    • STOCK INFORMATION
      • HISTORICAL STOCK LOOKUP
      • INVESTMENT CALCULATOR
      • ANALYST COVERAGE
      • OWNERSHIP PROFILE
    • INVESTOR FAQ
    • CONTACT US

INVESTOR RELATIONS

  • OVERVIEW
  • PRESS RELEASES
  • EVENTS & PRESENTATIONS
  • CORPORATE GOVERNANCE
    • AUDIT COMMITTEE
    • REMUNERATION COMMITTEE
    • CODE OF ETHICS
    • MEMORANDUM AND ARTICLES OF ASSOCIATION
  • FINANCIAL INFORMATION
  • STOCK INFORMATION
  • INVESTOR FAQ
  • CONTACT US
Click to subscribe to Amarin Email Notifications.

INVESTOR RELATIONS

CODE OF ETHICS

The Board of Directors of Amarin have adopted a company-wide code of ethics.

The Code of Ethics is available for download in PDF format.


    Disclaimer | Privacy Policy | Website supported by and InnoTechLLC.us

© 2010 Amarin